Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Other Non-Current Assets of $11.3 million in Q1 2026, down 24.54% quarter-over-quarter from $15.0 million in Q4 2025, and down 26.97% on a YoY basis from $15.5 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 26.97% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $11.3 million (down 26.97% YoY), while the FY2025 annual figure was $15.0 million, down 8.74% from the prior year.
- Other Non-Current Assets was $11.3 million for Q1 2026 at Ascend Wellness Holdings, down from $15.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $25.7 million in Q1 2024 to a low of $11.3 million in Q1 2026.
- Historically, Other Non-Current Assets has averaged $18.4 million across 5 years, with a median of $19.3 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 2984.37% in 2022, then sank 39.76% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $19.3 million in 2022, then increased by 19.59% to $23.1 million in 2023, then slipped by 28.77% to $16.4 million in 2024, then declined by 8.74% to $15.0 million in 2025, then fell by 24.54% to $11.3 million in 2026.
- The last three Other Non-Current Assets figures came in at $11.3 million (Q1 2026), $15.0 million (Q4 2025), and $15.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.31 Mn |
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 15.34 Mn |
| Jun 30, 2025 | 15.37 Mn |
| Mar 31, 2025 | 15.49 Mn |
| Dec 31, 2024 | 16.43 Mn |
| Sep 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 19.89 Mn |
| Mar 31, 2024 | 25.71 Mn |
| Dec 31, 2023 | 23.06 Mn |
| Sep 30, 2023 | 19.77 Mn |
| Jun 30, 2023 | 19.95 Mn |
| Mar 31, 2023 | 19.61 Mn |
| Dec 31, 2022 | 19.28 Mn |
| Sep 30, 2022 | 18.84 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 19.93 Mn |
| Dec 31, 2021 | 19.57 Mn |
| Sep 30, 2021 | 19.76 Mn |
| Jun 30, 2021 | 21.84 Mn |